Cleveland Clinic is the latest health system to invest in drones that deliver prescription medications to patients' homes. 

Organizers estimate as many as 4,500 pharmacists and pharmacy technicians at CVS, Rite Aid and Walgreens are participating in a three-day walkout that began Oct. 30.

Michael Hogue, PharmD, CEO and executive vice president of the American Pharmacists Association, has issued a statement of support for the planned walkouts by Walgreens and CVS pharmacy employees that began Oct. 30. 

The FDA label for Ozempic does not mention muscle pain, but some patients taking the popular Type 2 diabetes drug for weight loss are experiencing the side effect, according to an Oct. 27 report in women's magazine First for Women.

A panel of FDA advisers concluded after hours of discussion Oct. 31 that the first CRISPR gene therapy candidate is safe enough for clinical use, The New York Times reported. 

'Pharmageddon' is the nickname for a planned walkout by pharmacists at U.S. drugstore chains set to begin Oct. 30, although there is no count for how many workers will participate.

Drugmaker Eli Lilly announced Oct. 26 that Omvoh, its ulcerative colitis medication, has received approval from the FDA. 

Sanofi said it plans to separate from its consumer healthcare business — a move the company says will allow it to focus more on creating "transformative medicine and vaccines." 

After the FDA told hospitals to not give preterm infants probiotics following one baby's death, the agency sent warning letters to Abbott Laboratories and Infinant Health. 

The FDA declared the shortage resolved for Pluvicto, a prostate cancer drug made by Novartis.